Latest News
Cepheid receives CE mark for IVDR‑compliant gastrointestinal PCR panel
...
Kelun-Biotech's SKB118 PD-1 x VEGF bispecific antibody receives Chinese regulatory Investigational New Drug approval
13 May 2026 - Sichuan Kelun-Biotech Biopharmaceutical Co, Ltd (6990.HK) a China-based biopharmaceutical company, announced on Tuesday that it has received a clinical trial notice from China s Center for Drug Evaluation (CDE) of the National Medical P...
WuXi Biologics named in 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index
13 May 2026 - WuXi Biologics (2269.HK), a China-based global Contract Research, Development and Manufacturing Organisation (CRDMO), announced on Tuesday that, in recognition of its continued efforts and performance in advancing sustainability, the Co...
Clearway Health recognised with 2026 Great Place To Work Certification for fourth consecutive year
13 May 2026 - Clearway Health, a Boston-based company that partners with hospitals and health systems to plan, build and operate specialty pharmacy programs, announced on Tuesday its 2026 Certification by Great Place To Work for the fourth consecutiv...
Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma
13 May 2026 - Servier, a France-based pharmaceutical company, announced on Tuesday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Emi-Le, an investigational ADC directed against B7-H4, a well-characte...